The 23 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 83.00, with a high estimate of 90.00 and a low estimate of 62.00. The median estimate represents a +10.68% increase from the last price of 74.99.
The current consensus among 25 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.68
Reporting Date Feb 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.